WALTHAM, Mass., Sept. 1, 2015 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced its participation in three upcoming investor conferences. The three conferences are:
- The 10th Annual Citi Biotech Day at the Mandarin Oriental Hotel in New York City on Wednesday, September 9 and Thursday, September 10, 2015. Mary Lynne Hedley, Ph.D., President and COO of TESARO, will participate in a panel titled "Novel Therapies, Novel Biomarkers and Novel Trials: Examining a New Era in Oncology" at 10:00 AM ET on September 10, as well as in investor meetings.
- The Baird 2015 Health Care Conference at the New York Palace Hotel in New York City on Thursday, September 10. Lonnie Moulder, CEO of TESARO, is scheduled to present an overview of the Company's business and development programs at 11:25 AM ET on September 10, and will also host investor meetings.
- The Leerink Partners Immuno-Oncology Roundtable at Le Parker Meridien Hotel in New York City on Thursday, October 1, 2015. Lonnie Moulder and Mary Lynne Hedley will participate in an analyst-led fireside chat from 10:30 to 10:50 AM ET, and in meetings with investors.
Live webcasts of the presentations at the Baird and Leerink conferences will be available by visiting the Investors section of the TESARO website at www.tesarobio.com. Archived replays of these webcasts will be available on the Company's website for 14 days following the conferences.
TESARO, Inc. is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients.
CONTACT: Jennifer Davis 1.781.325.1116 firstname.lastname@example.org